Madely Health Headlines Commentary for September 20, 2012

Source:

Experimental MS drug shown to reduce relapses: studies

Reference:

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis